IDIV-B:CA:TSX-Manulife Smart International Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 13.68

Change

+0.09 (+0.66)%

Market Cap

N/A

Volume

8.30K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.02 (+0.07%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.03 (+0.06%)

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

+0.29 (+0.90%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

+0.02 (+0.10%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.40 (+1.12%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.15 (+1.40%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing IDIV-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.76% 57% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.76% 54% F 46% F
Trailing 12 Months  
Capital Gain 18.75% 50% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.75% 48% F 44% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.96% N/A N/A 58% F
Dividend Return 5.96% N/A N/A 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.79% N/A N/A 57% F
Risk Adjusted Return 87.75% N/A N/A 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike